Ubs Group Ag Mersana Therapeutics, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 473,527 shares of MRSN stock, worth $965,995. This represents 0.0% of its overall portfolio holdings.

Number of Shares

473,527

Previous 34,983 1253.59%

Holding current value

$965,995

Previous $70,000 1177.14%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1.23 - $2.25 $539,409 - $986,724	438,544 Added 1253.59%	473,527 $894,000
Q2 2024 Aug 13, 2024	SELL	$2.0 - $4.45 $509,368 - $1.13 Million	-254,684 Reduced 87.92%	34,983 $70,000
Q1 2024 May 13, 2024	BUY	$2.16 - $5.94 $294,604 - $810,162	136,391 Added 88.98%	289,667 $1.3 Million
Q4 2023 Feb 09, 2024	BUY	$1.11 - $2.34 $106,929 - $225,419	96,333 Added 169.17%	153,276 $355,000
Q3 2023 Nov 09, 2023	SELL	$1.06 - $3.91 $123,674 - $456,195	-116,674 Reduced 67.2%	56,943 $72,000
Q2 2023 Aug 11, 2023	SELL	$3.08 - $9.55 $36,288 - $112,518	-11,782 Reduced 6.35%	173,617 $571,000
Q1 2023 May 12, 2023	SELL	$4.0 - $7.02 $412,816 - $724,492	-103,204 Reduced 35.76%	185,399 $761,000
Q4 2022 Feb 08, 2023	BUY	$5.65 - $7.86 $1.48 Million - $2.06 Million	262,308 Added 997.56%	288,603 $1.69 Million
Q3 2022 Nov 10, 2022	BUY	$4.63 - $8.0 $80,867 - $139,728	17,466 Added 197.83%	26,295 $178,000
Q2 2022 Aug 10, 2022	SELL	$2.84 - $5.0 $17,877 - $31,475	-6,295 Reduced 41.62%	8,829 $41,000
Q1 2022 May 16, 2022	SELL	$3.74 - $6.63 $620,985 - $1.1 Million	-166,039 Reduced 91.65%	15,124 $60,000
Q4 2021 Feb 14, 2022	BUY	$5.48 - $9.86 $509,267 - $916,309	92,932 Added 105.33%	181,163 $1.13 Million
Q3 2021 Nov 15, 2021	BUY	$8.56 - $14.47 $554,645 - $937,583	64,795 Added 276.48%	88,231 $832,000
Q2 2021 Aug 13, 2021	SELL	$13.28 - $18.07 $845,205 - $1.15 Million	-63,645 Reduced 73.09%	23,436 $318,000
Q1 2021 May 12, 2021	BUY	$15.31 - $26.52 $1.24 Million - $2.14 Million	80,726 Added 1270.28%	87,081 $1.41 Million
Q4 2020 Feb 11, 2021	BUY	$16.84 - $27.59 $57,306 - $93,888	3,403 Added 115.28%	6,355 $169,000
Q3 2020 Nov 12, 2020	BUY	$16.2 - $25.7 $4,584 - $7,273	283 Added 10.6%	2,952 $55,000
Q2 2020 Jul 31, 2020	SELL	$5.24 - $23.4 $117,517 - $524,791	-22,427 Reduced 89.36%	2,669 $62,000
Q1 2020 May 01, 2020	SELL	$4.41 - $9.28 $89,822 - $189,015	-20,368 Reduced 44.8%	25,096 $146,000
Q4 2019 Feb 14, 2020	BUY	$1.45 - $6.73 $24,580 - $114,086	16,952 Added 59.46%	45,464 $261,000
Q3 2019 Nov 14, 2019	BUY	$1.54 - $4.2 $32,360 - $88,254	21,013 Added 280.21%	28,512 $45,000
Q2 2019 Aug 14, 2019	BUY	$3.84 - $6.4 $23,001 - $38,336	5,990 Added 396.95%	7,499 $30,000
Q1 2019 May 14, 2019	SELL	$3.51 - $7.3 $20,365 - $42,354	-5,802 Reduced 79.36%	1,509 $8,000
Q4 2018 Feb 14, 2019	BUY	$3.45 - $9.72 $13,724 - $38,666	3,978 Added 119.35%	7,311 $30,000
Q3 2018 Nov 14, 2018	BUY	$10.0 - $19.02 $14,950 - $28,434	1,495 Added 81.34%	3,333 $33,000
Q2 2018 Aug 14, 2018	BUY	$14.2 - $22.68 $2,939 - $4,694	207 Added 12.69%	1,838 $33,000
Q1 2018 May 15, 2018	BUY	$13.56 - $18.48 $4,678 - $6,375	345 Added 26.83%	1,631 $26,000
Q4 2017 Feb 14, 2018	SELL	$14.95 - $19.9 $4,544 - $6,049	-304 Reduced 19.12%	1,286 $21,000
Q3 2017 Nov 14, 2017	SELL	$14.8 - $18.06 $1,406 - $1,715	-95 Reduced 5.64%	1,590 $28,000
Q2 2017 Aug 14, 2017	BUY	N/A	1,685	1,685 $24,000

Others Institutions Holding MRSN

# of Institutions

121

Shares Held

116M

Call Options Held

233K

Put Options Held

457K

View Full List

About Mersana Therapeutics, Inc.

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $198M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

More about MRSN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account